Keywords: Infectious Disease, Brain, PASC, COVID-19
Motivation: Recognizing neurological symptoms in Post-Acute Sequelae of COVID-19 (PASC), this study investigates neuroinflammatory markers to develop reliable neuroimaging diagnostics.
Goal(s): To validate CoreFA, a data-driven imaging marker, for detecting white matter changes and to explore its correlation with [18F]FEPPA PET neuroinflammatory markers.
Approach: Diffusion MRI-derived fractional anisotropy (FA) was assessed in white matter tracts to derive CoreFA. CoreFA was validated in a prospective cohort and examined for association with neuroinflammation via FEPPA PET.
Results: CoreFA demonstrated high diagnostic accuracy (AUC = 0.81 for initial group; AUC = 0.77 for prospective cohort). [18F]FEPPA PET scans confirmed neuroinflammation in regions with reduced FA.
Impact: The strong correlation between CoreFA and neuroinflammatory markers from PET imaging provides a potential biomarker for assessing PASC-related brain changes.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords